PMID:16630341
| Citation |
Campbell, KJ, O'Shea, JM and Perkins, ND (2006) Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. BMC Cancer 6:101 |
|---|---|
| Abstract |
While many common chemotherapeutic drugs and other inducers of DNA-damage result in both NF-kappaB nuclear translocation and DNA-binding, we have previously observed that, depending on the precise stimulus, there is great diversity of the function of NF-kappaB. In particular, we found that treatment of U-2 OS osteosarcoma cells with the anthracycine daunorubicin or with ultraviolet (UV-C) light resulted in a form of NF-kappaB that repressed rather than induced NF-kappaB reporter plasmids and the expression of specific anti-apoptotic genes. Anthracyclines such as daunorubicin can induce DNA-damage though inhibiting topoisomerase II, intercalating with DNA and undergoing redox cycling to produce oxygen free radicals. In this study we have investigated other anthracyclines, doxorubicin and aclarubicin, as well as the anthracenedione mitoxantrone together with the topoisomerase II inhibitor ICRF-193, which all possess differing characteristics, to determine which of these features is specifically required to induce both NF-kappaB DNA-binding and transcriptional repression in U-2 OS cells. |
| Links |
PubMed PMC1459870 Online version:10.1186/1471-2407-6-101 |
| Keywords |
Antibiotics, Antineoplastic/pharmacology; Antineoplastic Agents/pharmacology; Catechin/analogs & derivatives; Catechin/therapeutic use; Cell Line, Tumor; DNA Damage; Daunorubicin/pharmacology; Doxorubicin/pharmacology; Enzyme Inhibitors/pharmacology; Free Radicals; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Intercalating Agents/pharmacology; Mitoxantrone/therapeutic use; NF-kappa B/metabolism; Osteosarcoma/drug therapy; Oxidation-Reduction; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase II Inhibitors; Transcription, Genetic |
| edit table |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
<annotationlinks/>
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
References
See Help:References for how to manage references in EcoliWiki.